Citations

Mayo Clinic

Showing 10 of 108523 citations.

Most patients with a small papillary thyroid carcinoma enjoy an excellent prognosis and may be managed with minimally invasive therapy or active surveillance
Castro, M. Regina , Ryder, Mabel , Brito, Juan P. , Hay, Ian D. , Morris, John C., Ryder, Mabel , Brito, Juan P

Cancer | June 16, 2015 | Volume: 121 | Issue: 18 | Pages: 3364-3365

10.1002/cncr.29468 | PMID 26079806 Get It

Concurrent activating KIT mutations in systemic mastocytosis
Finke, Christy M. , Zblewski, Darci, Hanson, Curtis A. , Ketterling, Rhett P. , Butterfield, Joseph H. , Tefferi, Ayalew , Pardanani, Animesh , Lasho, Terra L. , Ketterling, Rhett P

British Journal of Haematology | June 16, 2015 | Volume: 173 | Issue: 1 | Pages: 153-156

10.1111/bjh.13560 | PMID 26080027 Get It

Intrapulmonary vascular dilatations are common in portopulmonary hypertension and may be associated with decreased survival
Fussner, Lynn A. , Cartin‐Ceba, Rodrigo , Lin, Grace , Watt, Kymberly D. , Krowka, Michael J. , Iyer, Vivek

Liver Transplantation | June 16, 2015 | Volume: 21 | Issue: 11 | Pages: 1355-1364

10.1002/lt.24198 | PMID 26077312 Get It

Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (POPH) are pulmonary vascular complications of portal hypertension with divergent clinicopathologic features and management. The presence of intrapulmonary vascular dilatations (IPVDs), detected by agitated saline contrast‐enhanced transthoracic echocardiography (cTTE), is an essential feature of HPS but is not typically characteristic of POPH. Although IPVDs have been reported rarely in POPH, the prevalence and significance of this finding have not been systematically studied. We conducted a retrospective chart review of 80 consecutive patients diagnosed with POPH from January 1, 2002 to June 30, 2014 with documentation of cTTE findings, pulmonary hemodynamics, oxygenation, and survival. A total of 34 of the 80 patients (42%) underwent cTTE during initial diagnosis of POPH. IPVDs were detected in 20/34 patients (59%); intracardiac shunting was detected in 9/34 patients (26%; 4 also had IPVDs); and 9 patients (26%) had negative cTTE with no evidence of IPVD or intracardiac shunting. Patients with IPVD had decreased survival as compared to those without IPVD (P = 0.003), a trend that persisted after exclusion of liver transplant recipients (P = 0.07). The IPVD group had a trend toward higher Model for End‐Stage Liver Disease score with and without incorporating sodium (MELD or MELD‐Na; P = 0.05 for both). The right ventricular index of myocardial performance (RIMP) was lower in the IPVD group (median, 0.4 versus 0.6; P = 0.006). Patients with moderate or large IPVDs (n = 6) had worse oxygenation parameters (partial pressure of arterial oxygen, diffusing capacity of the lung for carbon monoxide, and alveolar‐arterial oxygen gradient) as compared to the rest of the cohort. Unexpectedly, IPVDs were frequently documented in POPH and associated with decreased survival. To further understand this observation, we recommend screening for IVPD in all patients with POPH. Liver Transpl 21:1355‐1364, 2015. © 2015 AASLD.
Period Prevalence of Ketamine-Propofol Admixture “Ketofol” in the Operating Room among Anesthesia Providers at an Academic Medical Center
Smischney, Nathan J. , Olson, Alliene N, Rao, Willow R, Marienau, Mary E

Medical Science Monitor | June 16, 2015 | Volume: 21 | Issue: No issue available | Pages: 1737-1744

10.12659/msm.893944 | PMID 26077108 Get It

Cardiac Metabolic Alterations in Hypertensive Obese Pigs
Li, Zi-Lun, Eirin, Alfonso , Ebrahimi, Behzad , Pawar, Aditya S. , Zhu, Xiang-Yang, Lerman, Lilach O. , Zhang, Xin , Lerman, Amir , Eirin, Alfonso

Hypertension | June 16, 2015 | Volume: 66 | Issue: 2 | Pages: 430-436

10.1161/hypertensionaha.115.05478 | PMID 26077566 Get It

Obesity and hypertension are major risk factors for cardiovascular diseases, and their growing coexistence accounts for an increase in adverse cardiac events, but the mechanisms are yet to be determined. We hypothesized that obesity exacerbates mitochondrial dysregulation imposed by hypertension and augments left ventricular dysfunction. Obesity-prone Ossabaw pigs were randomized to lean (standard diet) and obese (high-fat diet), without (Lean-sham and Obese-sham) or with renovascular hypertension (Lean-hypertension and Obese-hypertension), induced after 12 weeks of diet (n=7 each). Cardiac function, myocardial perfusion and oxygenation, and microvascular remodeling were assessed 4 weeks later. Mitochondrial biogenesis signals and structural proteins, respiratory chain complex activities, and mitochondrial self-degradation were examined, as was fibrosis. Obesity alone exerted no apparent effect on mitochondrial dynamics, but aggravated in hypertensive hearts the reduction of mitochondrial proteins, deoxyribonucleic acid content, and respiratory chain complex IV subunits activity, and amplified mitochondrial self-degradation. Synergistic interaction of obesity with hypertension also exacerbated myocardial fibrosis and left ventricular diastolic dysfunction. Mitochondrial content, respiratory chain complex IV subunits activity, and mitophagy were correlated with myocardial fibrosis. These findings suggest that obesity aggravates in renovascular hypertension cardiac mitochondrial aberrations. Mitochondrial function may regulate the progression of cardiac injury and functional deterioration in hypertension concomitant with obesity.
Long-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast Cancer
Sparano, Joseph A. , Martino, Silvana, Ligibel, Jennifer A. , Perez, Edith A. , Saphner, Tom, Wolff, Antonio C. , Wood, William C., Davidson, Nancy E. , Zhao, Fengmin , Sledge, George W. , Wolff, Antonio C , Sparano, Joseph A

Journal of Clinical Oncology | June 16, 2015 | Volume: 33 | Issue: 21 | Pages: 2353-2360

10.1200/jco.2015.60.9271 | PMID 26077235 Get It

Purpose To determine long-term outcomes in a clinical trial evaluating the role of taxane type and schedule in operable breast cancer and evaluate the impact of obesity and black race on outcome. Patients and Methods A total of 4,954 eligible women with stage II to III breast cancer treated with four cycles of doxorubicin plus cyclophosphamide were randomly assigned to receive paclitaxel or docetaxel every 3 weeks for four doses or weekly for 12 doses using a 2 × 2 factorial design. The primary end point was disease-free survival (DFS). Results are expressed as hazard ratios (HRs) from Cox proportional hazards models. All P values are two sided. Results When compared with the standard every-3-week paclitaxel arm, after a median follow-up of 12.1 years, DFS significantly improved and overall survival (OS) marginally improved only for the weekly paclitaxel (HR, 0.84; P = .011 and HR, 0.87; P = .09, respectively) and every-3-week docetaxel arms (HR, 0.79; P = .001 and HR, 0.86; P = .054, respectively). Weekly paclitaxel improved DFS and OS (HR, 0.69; P = .010 and HR, 0.69; P = .019, respectively) in triple-negative breast cancer. For hormone receptor–positive, human epidermal growth factor receptor 2–nonoverexpressing disease, no experimental arm improved OS, and black race and obesity were associated with increased risk of breast cancer recurrence and death. Conclusion Improved outcomes initially observed for weekly paclitaxel were qualitatively similar but quantitatively less pronounced with longer follow-up, although exploratory analysis suggested substantial benefit in triple-negative disease. Further research is required to understand why obesity and race influence clinical outcome in hormone receptor–positive disease.
Response characteristics of esophageal balloon catheters handmade using latex and nonlatex materials
Lalande, Sophie , Hyatt, Robert E., Johnson, Bruce D. , Cross, Troy J.

Physiological Reports | June 16, 2015 | Volume: 3 | Issue: 6 | Pages: e12426

10.14814/phy2.12426 | PMID 26077619 Get It

Lynch syndrome and cervical cancer
Antill, Yoland , Win, Aung Ko , Thompson, Tina , Walsh, Michael D. , Cummings, Margaret C. , Gallinger, Steven , Lindor, Noralane M. , Haile, Robert W. , Tucker, Katherine , Buchanan, Daniel D. , Young, Joanne , Winship, Ingrid , Jenkins, Mark A. , Tucker, Kathy , Dowty, James G. , Marchand, Loı̈c Le , Hopper, John L. , Newcomb, Polly A. , Church, James M. , Buchanan, Daniel D , Win, Aung K , Jenkins, Mark A , Haile, Robert W , Winship, Ingrid M

International Journal of Cancer | June 15, 2015 | Volume: 137 | Issue: 11 | Pages: 2757-2761

10.1002/ijc.29641 | PMID 26077226 Get It

Carriers of germline mutations in DNA mismatch repair (MMR) genes are at increased risk of several cancers including colorectal and gynecologic cancers (Lynch syndrome). There is no substantial evidence that these mutations are associated with an increased risk of cervical cancer. A total of 369 families with at least one carrier of a mutation in a MMR gene (133 MLH1, 174 MSH2, 35 MSH6 and 27 PMS2) were ascertained via population cancer registries or via family cancer clinics in Australia, New Zealand, Canada, and USA. Personal and family histories of cancer were obtained from participant interviews. Modified segregation analysis was used to estimate the hazard ratio (incidence rates for carriers relative to those for the general population), and age‐specific cumulative risks of cervical cancer for carriers. A total of 65 cases of cervical cancer were reported (including 10 verified by pathology reports). The estimated incidence was 5.6 fold (95% CI: 2.3–13.8; p = 0.001) higher for carriers than for the general population with a corresponding cumulative risk to 80 years of 4.5% (95% CI: 1.9–10.7%) compared with 0.8% for the general population. The mean age at diagnosis was 43.1 years (95% CI: 40.0–46.2), 3.9 years younger than the reported USA population mean of 47.0 years (p = 0.02). Women with MMR gene mutations were found to have an increased risk of cervical cancer. Due to limited pathology verification we cannot be certain that a proportion of these cases were not lower uterine segment endometrial cancers involving the endocervix, a recognized cancer of Lynch syndrome.
Unraveling N-Terminal Pro–B-Type Natriuretic Peptide: Another Piece to a Very Complex Puzzle in Heart Failure Patients
Jaffe, Allan S. , Apple, Fred S. , Vodovar, Nicolas , Jaffe, Allan S. , Mebazaa, Alexandre

Clinical Chemistry | June 15, 2015 | Volume: 61 | Issue: 8 | Pages: 1016-1018

10.1373/clinchem.2015.243626 | PMID 26078443 Get It

Review: Intensive blood pressure control reduces retinopathy in diabetes
Smith, Steven A., Tamhane, Shrikant

Annals of Internal Medicine | June 15, 2015 | Volume: 162 | Issue: 12 | Pages: JC7

10.7326/acpjc-2015-162-12-007 | PMID 26075784 Get It